1.Schimmelpenning syndrome with Didymosisaplasticosebacea in an infant
Jo Faustine Q. Manzano ; Victoria P Guillano
Journal of the Philippine Dermatological Society 2018;27(2):66-69
Introduction:
Schimmelpenning syndrome may encompass abnormalities of the cardiovascular, skeletal, ophthalmologic
and urogenital systems. Nevus sebaceous is a hallmark finding and ophthalmologic findings are seen in 59% of the cases
which include colobomas and choristomas.
Case Summary:
A 1-month-old female presented with a verrucous plaque over the scalp and right zygomatic area upon
birth. Physical examination reveals a linear yellowish alopecic verrucous plaque over the right frontal region, yellowish
alopecic verrucous plaque topped with a skin colored papule over the right zygomatic region, conjunctival mass over the
right eye and an atrophic patch with areas of circular erosion over the right occipital region. Ballard score and reflexes
were appropriate for gestational age. Newborn screening was normal and otoacoustic-emission-test revealed no hearing
loss. She was referred to an ophthalmologist and was assessed to have a lipodermoid, right upper eyelid and optic nerve
coloboma. Cranial CT scan is unremarkable. Histopathology showed an increase in number of sebaceous glands with
malformed hair units. She was managed holistically and does not have seizures and no secondary development of tumors
in the nevus sebaceous.
Conclusion
Schimmelpenning syndrome is usually associated with the clinical triad of nevus sebaceous, mental
retardation and seizures. In this case, seizures were absent, however, there is an associated lipodermoid, right upper
eyelid and right optic nerve coloboma. In addition, she also presented with aplasia cutis congenita. Hence, it is important
to look for other manifestations when patients present with nevus sebaceous because management requires collaboration
with different specialties.
Nevus, Sebaceous of Jadassohn
3.Psoriasis Foundation of the Philippines, Inc.
Maria Vinna Nicodemus Crisostomo ; Margaret Stephanie L Jimenez ; Jo Faustine Q Manzano ; Victoria P Guillano
Southern Philippines Medical Center Journal of Health Care Services 2021;7(1):1-2
The Psoriasis Foundation of the Philippines, Inc. (PFPI), is a non-profit organization in Davao City. The organization was founded in 1997 by dermatologists from Mindanao, with Dr. Carlos Pacheco as the founding president. In the same year, the PFPI was registered at the Securities and Exchange Commission (SEC).
The foundation was established with the goal of improving the quality of life of patients with psoriasis. Its founders believed that they can achieve these goals by: 1. facilitating patient access to medical consultations and medications for psoriasis; 2. carrying out activities that provide social and financial support to patients and their families, and 3. promoting the conduct of research that can be used to improve the management of psoriasis.
In order to do this, the PFPI partnered with the Southern Philippines Medical Center (SPMC) Department of Dermatology as it caters to numerous dermatological patients covering the Visayas and Mindanao region. With this, the PFPI was able to garner a wider grasp of psoriasis patients as well as the opportunity to work closely with their health care providers and aid patients not only medically but also in addressing various aspects of their well-being. This led to the establishment of the Psoriasis Club.
The Psoriasis Club currently has at least 30 members, composed of patients who have been diagnosed with psoriasis in the SPMC Department of Dermatology Clinic. The club holds monthly meetings and functions as a support group for patients and their family members, along with their healthcare providers. This has led to better monitoring of patients, increase in compliance to treatment, and stronger patient-doctor relationships. Further, the club has been able to build and strengthen relationships among psoriasis patients and their families, thereby increasing the size of their social support team. The club also implemented livelihood programs such as soap-, candle-, and Christmas decor-making in order to provide patients with skills and offer them financial security. In addition, the SPMC Department of Dermatology organizes fundraising events (e.g. postgraduate courses or conferences, advance movie screenings, pop-up thrift shops) every year to raise funds for psoriasis patients in order to generate revenue for their livelihood and medications.
The PFPI, together with the Philippine Dermatological Society, celebrates World Psoriasis Day every October. This annual event is attended by patients with psoriasis, family members, and healthcare workers. It is a time when patients are given an opportunity to share their personal health experiences to dispel stigma and myths regarding psoriasis. It also impels the lay people to partner with them as they lobby for better access to health care and affordable treatments. The event also provides entertaining activities and offers free dermatological consultations.
In 2015, the PFPI, in partnership with the SPMC Department of Dermatology, also started the Psoriasis Registry (PsoReg) in Davao City to keep track of psoriasis patients’ disease progression or improvement. This registry contains the sociodemographic information, clinical profiles, efficacy or failure of treatment, and quality of life among patients with psoriasis in a tertiary government hospital and private dermatology clinics. The PsoReg also aims to facilitate further studies in the disease, influence health policies, and promote the creation of a unified national registry for the country.
Currently, the PFPI is under the leadership of Dr. Victoria P. Guillano. As a partner institution of PFPI, the SPMC Department of Dermatology provides support to the foundation, especially in terms of human resources, financial assistance, and technical expertise from its pool of consultants, residents and health staff.
Since the establishment of the PFPI, efforts toward improving psoriasis healthcare have been geared towards lobbying for the inclusion of psoriasis in the list of subsidized medical cases by the Philippine Health Insurance Corporation (PhilHealth). This is done with the help of Rep. Scott Davies Lanete, MD, who principally authored the House Resolution 1818 that would make treatment readily available for patients with psoriasis.
In 2019, the PFPI received a pharmaceutical company-funded grant that enabled the foundation to implement project Psoriasis Health Innovations (Psor-HI). This project aims to link the patients, healthcare providers, and policy makers to develop and strengthen dermatologic care for psoriasis patients. Through this project, the PFPI was able to easily reach patients and their families in Davao City, Zamboanga City, Tagum City, and Cebu City. Psor-HI was able to connect with municipal health workers, allied medical professionals, and general practitioners in these areas and connect them to the PFPI where they were able to provide vital information on psoriasis and its appropriate management. In addition, health workers with limited access to specialized dermatologic care were properly guided and enhanced their capacities to provide the best care for their psoriasis patients.
The PFPI plans to engage local partners in the community in the future to strengthen patient engagement. Since psoriasis is currently not included in the health programs of the Department of Health (DOH), the PFPI envisions the integration of psoriasis education in the list of non-communicable diseases being addressed and monitored by the DOH. The PFPI will continue to be an active advocate in the achievement of accessible and affordable health services for patients with psoriasis.